Dr. Pawan Gupta and Dr. Jonathan Celli were honored with the USISTEF 2024 Award for AI-Enabled Oral Cancer Screening and Treatment Project
We are thrilled to announce that Dr. Pawan Gupta, representing ICanCaRe (Indian partner), and Dr. Jonathan Celli from Photodynamic Solutions Inc., Boston (U.S. partner), have been honored with the prestigious USISTEF 2024 Award. This recognition was awarded under the joint call for proposals on ‘Critical and Emerging Technologies and Artificial Intelligence for Transforming Lives’ by the United States-India Science and Technology Endowment Fund. The project focuses on AI-enabled technology for oral cancer screening and treatment, addressing a significant healthcare challenge in India.
The award ceremony took place on October 10, 2024, at the Leela Palace, New Delhi. The Hon. Eric Garcetti, U.S. Ambassador to India, and the Hon. Dr. Jitendra Singh, Union Minister of State for Earth Sciences and Science & Technology, presented the award. Dr. Pawan Gupta graciously accepted the award certificate on behalf of both organizations, marking a significant milestone in the collaborative fight against oral cancer.
Oral cancer poses a severe public health challenge in India, largely fueled by high rates of tobacco use, betel nut consumption, and low awareness. Compounding these issues is the lack of adequate healthcare access, particularly in rural areas, which makes early detection and treatment difficult. These obstacles make it critical to develop new solutions to overcome the barriers to effective oral cancer screening and management.
This project aims to revolutionize oral cancer detection and treatment by developing a comprehensive, portable, and low-cost solution targeting high-risk populations. The innovative technology will incorporate AI-assisted autofluorescence and white light imaging for optical pathology diagnosis, ensuring early and accurate identification of pre-malignant and malignant lesions. Treatment will be initiated with tobacco cessation and facilitated through photo-biomodulation (PBM) and photodynamic therapy (PDT) for on-the-spot care of potentially pre-malignant lesions.
With this technology, ICanCaRe and Photodynamic Solutions Inc., Boston, are committed to transforming the way oral cancer is diagnosed and treated, particularly in underserved areas. We extend our heartfelt thanks to the entire team working on this groundbreaking initiative. Together, we strive to create a future where early detection of oral cancer is accessible to all, improving patient outcomes and saving lives.
Stay tuned for more updates on this revolutionary project!
#USISTEF #AwardWinner #CancerCare #AIForHealth #ICanCaRe #MaxOncology #InnovationInHealthcare #photodynamicsolutions #photobiomodulations #pawangupta #jonathancelli